Neoadjuvant Bevacizumab, Capecitabine and Radiation Therapy With or Without Oxaliplatin Locally Advanced Rectal Cancer

NCT00828672 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Rectal Cancer

Interventions

DRUG: Oxaliplatin
DRUG: Bevacizumab
DRUG: Capecitabine
RADIATION: radiotherapy

Sponsor

Universitaire Ziekenhuizen KU Leuven